MAMaria Alves

Maria Alves

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maria Alves has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Condylomata lata: o impacto dos determinantes sociais da saúde na apresentação da sífilis

    by Maria Alves, Rita Jesus

    Discussão do caso: Apresenta-se o caso de uma mulher de 56 anos, em situação de sem-abrigo, com antecedentes de infeção crónica pelo vírus da hepatite B e consumo excessivo de álcool e tabaco, que recorreu ao serviço de urgência por dermatose dolorosa e pruriginosa com quatro meses de evolução. O exame objetivo revelou múltiplas lesões ovóides, planas, de base larga e aspeto mucoso, algumas umbilicadas, predominantemente localizadas na região genital e em áreas intertriginosas. A doente referia contacto sexual sem preservativo em contexto de agressão sexual, três semanas antes do surgimento das lesões. Laboratorialmente, apresentava VDRL 1/128 e TPHA positivo, tendo sido excluídas outras etiologias infeciosas. A biópsia cutânea confirmou o diagnóstico de condylomata lata, manifestação característica da sífilis secundária. Apesar do abandono precoce do seguimento, verificou-se posteriormente resolução clínica e serológica. Conclusão: Este caso ilustra uma apresentação exuberante e atípica da sífilis secundária, salientando a sua natureza proteiforme e o impacto dos determinantes sociais da saúde na gravidade da doença e no atraso diagnóstico, particularmente em populações socialmente vulneráveis.

  • Open Access

    HIV Infection in Portugal: Measuring the Time Between Linkage to Care and Antiretroviral Therapy Initiation

    by Ana Virgolino, Carolina Ferraz, Vanessa Nicolau, Rui Cortes, Aida Pereira, Fernando Maltez, João Paulo Caldas, João Lourinho, Maria Alves, Inês Caetano, et al.

    Background/Objectives: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) can improve clinical outcomes. However, ART commencement is often delayed. Portugal, despite having one of the highest new HIV diagnosis rates within the European Union, has limited available national-level data. Prior evidence from 2017 to 2018 suggests that the average time to ART initiation exceeds the recommendations for optimal patient benefits. This study aimed to determine the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals. It was hypothesized that newly diagnosed PLWH in Portugal experience a delay in ART initiation beyond the recommended timeframe. Methods: A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage most HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. Results: A total of 2229 cases (out of 3434 received) from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. Conclusions: Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.


  • Open Access

    HIV Infection in Portugal: Measuring the Time Between Linkage to Care and Antiretroviral Therapy Initiation

    by Ana Virgolino, Carolina Ferraz, Vanessa Nicolau, Rui Cortes, Aida Pereira, Fernando Maltez, João Paulo Caldas, João Lourinho, Maria Alves, Inês Caetano, et al.

    Background/Objectives: The timely initiation of antiretroviral therapy (ART) in persons living with HIV (PLWH) improves clinical outcomes. However, ART commencement is often delayed. Portugal, which has one of the highest new HIV diagnosis rates within the European Union, has limited available data. Evidence from 2017-2018 suggests that the average time to ART initiation exceeds the recommendations for optimal benefits. This study aimed to assess the number of days from the first hospital appointment to the commencement of ART among newly diagnosed PLWH in Portugal between 2017 and 2022 at the national level and across different hospitals within the country. Methods: A retrospective analysis of records from Portuguese public tertiary care hospitals, which manage the majority of HIV patients, was conducted. Descriptive statistics (measures of central tendency, dispersion, and frequency) were applied, along with association tests and a binary logistic regression model to examine factors influencing the timing of ART initiation. Results: A total of 2,229 cases from 19 hospitals were considered eligible. The median time interval between the first hospital appointment and ART initiation was 29.00 days, with a decreasing tendency between 2017 and 2022. Patients initiating therapy after 14 days had higher CD4 levels and lower viral loads compared to those starting within 14 days, with statistical significance. Conclusions: Continuous and regular monitoring of key indicators, such as the time to ART initiation, is pivotal for assessing the effectiveness of HIV treatment programs and pinpointing areas in need of improvement.